✦ LIBER ✦

Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novoBRCA1mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing

✍ Scribed by Kim De Leeneer; Ilse Coene; Brecht Crombez; Justine Simkens; Rudy Van den Broecke; Alain Bols; Barbara Stragier; Ilse Vanhoutte; Anne De Paepe; Bruce Poppe; Kathleen Claes

Publisher: Springer US
Year: 2011
Tongue: English
Weight: 537 KB
Volume: 132
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-011-1544-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevalence of BRCA1 and BRCA2 mutations

Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients

✍ Muhammad U. Rashid; Anbreen Zaidi; Diana Torres; Faisal Sultan; Axel Benner; Bil 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 312 KB 👁 2 views

## Abstract Among Asian countries, Pakistan has the highest rates of breast and ovarian cancer. To assess the contribution of the __BRCA1__ and __BRCA2__ germ line mutations to these high rates, we conducted the first study of 176 Pakistani breast and ovarian cancer patients, selected on family his

Prevalence of founder BRCA1 and BRCA2 mu

Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in hungary

✍ Marco Van der Looij; Csilla Szabo; Istvan Besznyak; Gyorgy Liszka; Bela Csokay; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 55 KB 👁 2 views

We have investigated the impact of BRACA1 and BRACA2 mutations that were frequently identified among Hungarian high-risk breast-ovarian cancer families (Ramus et al., 1997b, AJHG), on the development of breast and ovarian cancer in the general Hungarian population. The prevalence of 3 BRCA1 mutation

Prevalence of BRCA1 genomic rearrangemen

Prevalence of BRCA1 genomic rearrangements in a large cohort of Italian breast and breast/ovarian cancer families without detectable BRCA1 and BRCA2 point mutations

✍ Simona Agata; Alessandra Viel; Lara Della Puppa; Laura Cortesi; Giusi Fersini; M 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 1 views

The presence of genomic rearrangements of the BRCA1 gene in breast and/or ovarian cancer families has been intensively investigated in patients from various countries over the last years. A number of different rearrangements have been reported by several studies that clearly document the involvement

Prevalence of BRCA1 and BRCA2 germline m

Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: A population-based study

✍ Silvia de Sanjosé; Mélanie Léoné; Victoria Bérez; Angel Izquierdo; Rebeca Font; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 82 KB 👁 1 views

## Abstract Our aim was to estimate the prevalence of mutations in the __BRCA1__ and __BRCA2__ genes among unselected incident cases of breast cancer in young women. We identified 158 incident breast cancer cases diagnosed before age 46 years in predefined geographic areas in Girona and Tarragona,

Prevalence of five previously reported a

Prevalence of five previously reported and recurrent BRCA1 genetic rearrangement mutations in 20,000 patients from hereditary breast/ovarian cancer families

✍ Brant C. Hendrickson; Thaddeus Judkins; Benjamin D. Ward; Kristilyn Eliason; Ami 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

## Abstract Many rearrangement mutations in the __BRCA1__ gene have been identified. It is becoming clear that some of these mutations are prevalent, and therefore their detection is necessary in order for clinical genetic tests to have high sensitivity. Published information on particular rearrang

Mutation analysis of the BRCA1 and BRCA2

Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6/16 Flemish families with breast and/or ovarian cancer but not in 12 sporadic patients with early-onset disease

✍ Kathleen Claes; Eva Machackova; Michel De Vos; Geert Mortier; Anne De Paepe; Lud 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB 👁 2 views

Germline mutations within the adenomatous polyposis coli (APC) gene, a tumor suppressor gene, are responsible for most cases of familial adenomatous polyposis (FAP), an autosomal dominantly inherited predisposition to colorectal cancer. To date, more than 300 germ-line causative mutations within thi